1271P - KRAS mutations(m) in lung adenocarcinoma (AC) patients(p) receiving standard chemotherapy (ch) and immune checkpoint inhibitors (i-CI): Impact of KRAS clonality and coexisting TP53m
| Autor: | Aranda, N. Pardo, Ruiz, F., Marti, A. Martinez, Cedres, S., Mendivil, A. Navarro, fuente, Idela, de Castro, A. Martinez, Vivancos, A., Dienstmann, R., Felip, E. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi440-vi440 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|